Oracle Life Sciences Central Designer 7.0.1.0 Remote Code Execution
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.8 | $0-$5k | 0.00 |
Summary
A vulnerability described as critical has been identified in Oracle Life Sciences Central Designer 7.0.1.0. This issue affects some unknown processing. The manipulation results in Remote Code Execution. This vulnerability is known as CVE-2026-21923. It is possible to launch the attack remotely. No exploit is available. Upgrading the affected component is recommended.
Details
A vulnerability was found in Oracle Life Sciences Central Designer 7.0.1.0. It has been classified as critical. Affected is an unknown code block. The manipulation with an unknown input leads to a remote code execution vulnerability. This is going to have an impact on confidentiality, integrity, and availability. CVE summarizes:
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
The advisory is shared for download at oracle.com. This vulnerability is traded as CVE-2026-21923 since 01/05/2026. The exploitability is told to be easy. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 01/21/2026).
Upgrading eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2026-3586). Once again VulDB remains the best source for vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.9VulDB Meta Temp Score: 6.8
VulDB Base Score: 7.3
VulDB Temp Score: 7.0
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 6.5
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Remote Code ExecutionCWE: Unknown
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Timeline
01/05/2026 CVE reserved01/20/2026 Advisory disclosed
01/20/2026 VulDB entry created
01/21/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-21923 (🔒)
GCVE (CVE): GCVE-0-2026-21923
GCVE (VulDB): GCVE-100-342060
EUVD: 🔒
Entry
Created: 01/20/2026 23:39Updated: 01/21/2026 22:48
Changes: 01/20/2026 23:39 (61), 01/21/2026 22:48 (1)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.